Join
Live feed
·
INSIDERFilingvia Quantisnow
GenMark Diagnostics, Inc. logo

SEC Form 4: Michael Gleeson was granted 18,750 units of Common Stock and sold $51,012 worth of Common Stock (2,340 units at $21.80), increasing ownership by 4% to 414,388 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GNMK (GenMark Diagnostics, Inc.) and more on Quantisnow.